| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 8485- | MF, | doxoR, | Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells |
| - | in-vitro, | OS, | G292 |
| 8484- | MF, | doxoR, | Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells |
| - | in-vitro, | BC, | MDA-MB-231 |
| 9292- | MF, | Pulsed Electromagnetic Field Modulates Tendon Cells Response in IL-1β-Conditioned Environment |
| - | in-vivo, | Nor, | NA |
| 4015- | MF, | Evaluation of the PTEN and circRNA-CDR1as Gene Expression Changes in Gastric Cancer and Normal Cell Lines Following the Exposure to Weak and Moderate 50 Hz Electromagnetic Fields |
| - | in-vitro, | GC, | AGS | - | in-vitro, | Nor, | HU02 |
| 3740- | MF, | Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| - | Study, | Stroke, | NA |
| 4095- | MF, | Frequency-tuned electromagnetic field therapy improves post-stroke motor function: A pilot randomized controlled trial |
| - | Trial, | Stroke, | NA |
| 4097- | MF, | Theta Frequency Electromagnetic Stimulation Enhances Functional Recovery After Stroke |
| - | Trial, | Stroke, | NA |
| 4119- | MF, | Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer’s disease: a literature review |
| - | Review, | AD, | NA |
| 4096- | MF, | Extremely Low‐Frequency and Low‐Intensity Electromagnetic Field Technology (ELF‐EMF) Sculpts Microtubules |
| - | in-vitro, | AD, | NA |
| 4098- | MF, | Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients |
| - | Trial, | Stroke, | NA |
| 4102- | MF, | Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients |
| - | Human, | Stroke, | NA |
| 4103- | MF, | Comparing the Effects of Long-term Exposure to Extremely Low-frequency Electromagnetic Fields With Different Values on Learning, Memory, Anxiety, and β-amyloid Deposition in Adult Rats |
| - | in-vivo, | Nor, | NA |
| 4111- | MF, | Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell |
| - | Review, | Arthritis, | NA |
| 4148- | MF, | Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients |
| - | Human, | Stroke, | NA |
| 3473- | MF, | Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia |
| - | Human, | BPH, | NA |
| 6938- | MF, | Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model |
| - | in-vivo, | BPH, | NA |
| 6937- | MF, | Noninvasive treatment for men suffering from enlarged prostate |
| - | Review, | BPH, | NA |
| 6936- | MF, | Ex, | Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia |
| - | Trial, | BPH, | NA |
| 6941- | MF, | Ex, | The effects of pulsed electromagnetic field therapy on muscle strength and pain in patients with end-stage knee osteoarthritis: a randomized controlled trial |
| - | Trial, | Arthritis, | NA |
| 7390- | MF, | A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP |
| 7387- | MF, | Effects of Sinusoidal Magnetic Field Observed on Cell Proliferation, Ion Concentration, and Osmolarity in Two Human Cancer Cell Lines |
| - | in-vitro, | AML, | HL-60 | - | in-vitro, | adrenal, | SK-HEP-1 |
| 7384- | MF, | Reactive oxygen species (ROS) production in HepG2 cancer cell line through the application of localized alternating magnetic field |
| - | in-vitro, | Liver, | HepG2 |
| 7383- | MF, | Magneto mitochondrial dysfunction mediated cancer cell death using intracellular magnetic nano-transducers |
| - | vitro+vivo, | Var, | NA |
| 7391- | MF, | The effects of pulsed magnetic field exposure on the permeability of leukemia cancer cells |
| - | in-vitro, | AML, | K562 |
| 491- | MF, | Pre-exposure of neuroblastoma cell line to pulsed electromagnetic field prevents H2 O2 -induced ROS production by increasing MnSOD activity |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 192- | MF, | The use of magnetic fields in treatment of patients with rheumatoid arthritis. Review of the literature |
| - | Review, | Arthritis, | NA |
| 4571- | MF, | Magnetic Fields and Reactive Oxygen Species |
| - | Review, | Var, | NA |
| 4349- | MF, | Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial |
| - | Trial, | ostP, | NA |
| 4355- | MF, | Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism |
| - | in-vitro, | Nor, | C2C12 |
| - | in-vitro, | BC, | 4T1 | - | in-vitro, | BC, | MCF7 |
| 4569- | MFrot, | Case Report: A new noninvasive device-based treatment of a mesencephalic H3 K27M glioma |
| - | Case Report, | GBM, | NA |
| 9295- | MFrot, | Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T α-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways |
| - | in-vivo, | Park, | NA |
| 9297- | MFrot, | Intracellularly actuated biomimetic nanorobots for chemo-mechanical breast cancer therapy |
| - | in-vivo, | BC, | NA |
| 9298- | MFrot, | Impact of static and dynamic magneto-mechanical stimulation with vortex microdiscs on glioblastoma cells cultured on 2D substrates with physiological stiffness |
| - | in-vitro, | GBM, | GBM |
| 9299- | MFrot, | Multifocal transcranial stimulation in chronic ischemic stroke: A phase 1/2a randomized trial |
| - | Trial, | Stroke, | NA |
| 9300- | MFrot, | MNPs, | AgNPs, | Antibacterial Effects of Magnetically-Controlled Ag/Fe3O4 Nanoparticles |
| - | in-vitro, | Nor, | NA |
| 9269- | MFrot, | Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial (OMX-EFS-01) |
| - | Trial, | GBM, | NA |
| 9270- | MFrot, | Perspectives of biophysical therapies in glioblastoma |
| - | Review, | GBM, | NA |
| 8480- | MFrot, | Neuroprotective effect of RMF in a mouse model of sporadic Parkinson's disease |
| - | in-vivo, | Park, | NA |
| 8482- | MFrot, | Polyhedral magnetic nanoparticles induce apoptosis in gastric cancer stem cells and suppressing tumor growth through magnetic force generation |
| - | vitro+vivo, | GC, | NA |
| 8479- | MFrot, | doxoR, | Dual-targeting by rotating magnetic field-driven superparamagnetic bionic nanorobots for enhanced triple-negative breast cancer therapy |
| - | vitro+vivo, | BC, | 4T1 |
| 8478- | MFrot, | Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity |
| - | vitro+vivo, | Lung, | NA |
| 8477- | MFrot, | Urchin-like magnetic nanoparticles loaded with type X collagen siRNA and Stattic to treat triple negative breast cancer under rotating magnetic field like an "enchanted micro-scalpel" |
| - | Study, | BC, | NA |
| 8476- | MFrot, | Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment |
| - | in-vitro, | Var, | NA |
| 5242- | MFrot, | Rotating magnetic field downregulating type XI collagen to suppress triple-negative breast cancer metastasis by inactivating the ITGB1/FAK/YAP signaling pathway |
| - | in-vitro, | BC, | NA |
| 5535- | MFrot, | Spatiotemporal magnetic fields enhance cytosolic Ca2+ levels and induce actin polymerization via activation of voltage-gated sodium channels in skeletal muscle cells |
| - | in-vitro, | Nor, | NA |
| 187- | MFrot, | MF, | Method for noninvasive whole-body stimulation with spinning oscillating magnetic fields and its safety in mice |
| - | in-vivo, | GBM, | NA |
| 185- | MFrot, | MF, | Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device |
| - | Human, | GBM, | NA |
| 184- | MFrot, | MF, | Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells |
| - | in-vitro, | GBM, | GBM |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid